Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, indicating a newer version of the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor administrative update to the page version.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows an updated revision label from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision tag v3.6.2 appears and the older v3.6.0 tag is removed, indicating a small update to the page's version history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label. The recruitment status is updated to No longer looking for participants, and the revision tag changes from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page revision has been updated to v3.5.5, indicating a minor maintenance update to the page. This appears to be a backend or formatting adjustment rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.